Abstract
7003Background: We have previously reported high anti-tumor activity of CD19-targeted 19-28z chimeric antigen receptor (CAR) modified T cells in adult patients (pts) with relapsed or refractory (R/...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
